Limited Metastatic Disease
1 clinical trials · Condition
◉ Watch Limited Metastatic Disease
| Record | Firm | Date |
|---|---|---|
| Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR) (NCT02735850) | Maastricht Radiation Oncology | 2015-12-01 |
Track Limited Metastatic Disease automatically
Every clearance here is in the API, with alerts when new ones post.